Commercial Use

While ATCC views the MTA as an essential part of distributing its biological materials, the organization readily recognizes the potential utility of ATCC products in commercial applications. To help meet that need, ATCC has set up an out-licensing program that allows companies to use ATCC products for commercial purposes under a non-exclusive licensing agreement. Possible commercial uses of ATCC products that lie outside the scope of the MTA allowed through the ATCC licensing program include:

  • Sterility testing
  • Vaccine manufacture
  • Food & beverage manufacture — yogurt, soda, infant formula
  • Product testing
  • Clinical diagnostics
  • Wastewater treatment and septic additives
  • Contract pharmaceutical manufacture
  • Drug development
  • Contract research — drug discovery, preclinical services, screening
  • Medical devices
  • Nutraceuticals
  • Gene expression databases
  • Genome sequencing instrumentation
  • Government contracts
  • High-throughput technologies
  • Proficiency testing
  • Research reagents and tools
  • Stem cell R&D
  • Toxicology testing
  • Veterinary pharmaceuticals

 

Technologies Available for Licensing

Specific ATCC technologies/materials available for commercial licensing agreement are:

  • Master cell banks of Vero cells for vaccine manufacture
  • Mycoplasma detection kit (version 3)
  • Speciation kit
  • Materials in ATCC special collections (JHU, National Park Service)
  • Pre-1980 cell lines in ATCC collection

The licensing program for commercial use of ATCC products and use of the MTA for ATCC products in research both help protect the ability of ATCC to supply reference standards for the benefit of the scientific community.

For information about commercial use of ATCC materials, contact our Intellectual Property, Licensing and Services Department.